cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
0.4880
-0.0209 (-4.11%)
Aug 24, 2026, 4:00 PM EDT - Market closed
cbdMD Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 20.93 | 19.19 | 19.48 | 24.16 | 35.4 | 44.48 | |
Revenue Growth | 10.02% | -1.50% | -19.35% | -31.77% | -20.41% | 6.20% |
Cost of Revenue | 8.86 | 7.22 | 7.49 | 9.18 | 13.07 | 14.5 |
Gross Profit | 12.07 | 11.97 | 12 | 14.98 | 22.34 | 29.99 |
Selling, General & Admin | 13.52 | 11.99 | 13.27 | 18.93 | 33.29 | 43.37 |
Research & Development | 0.02 | 0.03 | 0.04 | 0.17 | 0.63 | 1.42 |
Amortization of Goodwill & Intangibles | 0.8 | 0.77 | 0.7 | 1.4 | 0.88 | - |
Other Operating Expenses | 0.41 | 0.98 | 0.86 | 3.34 | 3.89 | 3.79 |
Operating Expenses | 14.98 | 14.13 | 15.31 | 24.25 | 39.65 | 49.6 |
Operating Income | -2.9 | -2.16 | -3.32 | -9.27 | -17.31 | -19.62 |
Interest Expense | - | - | -0.03 | - | - | -0.03 |
Interest & Investment Income | 0.02 | 0.03 | - | 0.06 | 0.02 | - |
Other Non Operating Income (Expenses) | - | - | - | - | 0.24 | 0.03 |
EBT Excluding Unusual Items | -2.89 | -2.13 | -3.34 | -9.2 | -17.06 | -19.62 |
Merger & Restructuring Charges | - | - | - | - | -0.6 | - |
Impairment of Goodwill | - | - | - | - | -56.67 | - |
Gain (Loss) on Sale of Investments | - | - | - | -0.7 | -0.03 | 0.55 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.09 | - |
Asset Writedown | - | - | - | -13.22 | -4.29 | - |
Other Unusual Items | - | 0.09 | -0.36 | 0.19 | 8.47 | -5.22 |
Pretax Income | -2.89 | -2.04 | -3.7 | -22.94 | -70.08 | -24.29 |
Income Tax Expense | - | - | - | - | - | -0.9 |
Earnings From Continuing Operations | -2.89 | -2.04 | -3.7 | -22.94 | -70.08 | -23.39 |
Net Income | -2.89 | -2.04 | -3.7 | -22.94 | -70.08 | -23.39 |
Preferred Dividends & Other Adjustments | 0.19 | 2.33 | 4 | 4 | 4 | 2.55 |
Net Income to Common | -3.08 | -4.38 | -7.7 | -26.94 | -74.09 | -25.95 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 10 | 4 | 1 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 10 | 4 | 1 | 0 | 0 | 0 |
Shares Change | 382.43% | 646.22% | 113.25% | 52.31% | 8.76% | 21.62% |
EPS (Basic) | -0.32 | -1.09 | -14.29 | -106.57 | -446.37 | -170.04 |
EPS (Diluted) | -0.32 | -1.09 | -14.29 | -106.57 | -446.40 | -170.04 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -2.41 | -1.64 | -0.54 | -4.6 | -15.66 | -14.44 |
Free Cash Flow Per Share | -0.25 | -0.41 | -1.01 | -18.20 | -94.33 | -94.59 |
Gross Margin | 57.68% | 62.37% | 61.57% | 62.01% | 63.09% | 67.41% |
Operating Margin | -13.87% | -11.27% | -17.02% | -38.37% | -48.89% | -44.10% |
Profit Margin | -14.71% | -22.80% | -39.55% | -111.53% | -209.26% | -58.34% |
Free Cash Flow Margin | -11.51% | -8.53% | -2.79% | -19.04% | -44.22% | -32.45% |
EBITDA | -1.89 | -1.04 | -2.17 | -7.47 | -15.48 | -18.6 |
EBITDA Margin | -9.01% | -5.40% | -11.12% | -30.92% | -43.72% | -41.81% |
D&A For EBITDA | 1.02 | 1.13 | 1.15 | 1.8 | 1.83 | 1.02 |
EBIT | -2.9 | -2.16 | -3.32 | -9.27 | -17.31 | -19.62 |
EBIT Margin | -13.87% | -11.27% | -17.02% | -38.37% | -48.89% | -44.10% |
Revenue as Reported | 20.93 | 19.19 | 19.48 | 24.16 | 35.4 | 44.48 |